Medichem’s Rivaroxaban DCP approved and DMFs filed in EU & US

Medichem will be attending #DCATWeek2025

We’re excited to announce that Medichem will be attending #DCATWeek2025! This event is a key opportunity to strengthen #partnerships and explore new collaborations. With manufacturing sites in Sp.

Medichem will be attending PharmaSynergyRx 2025 for the first time

Medichem will be attending PharmaSynergyRx 2025 for the first time!📅 27th - 28th February 2025📍 Leonardo Royal Hotel, London City Medichem operates in Europe, with manufacturing sites in Spain an.

Medicines for Europe Executive Meeting: key challenges in Brussels

Yesterday, at the Medicines for Europe Executive Meeting in Brussels, we tackled key challenges, from strengthening resilient supply chains to fostering a strong off-patent sector—always with #patie.